Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing

European Journal of Clinical Pharmacology

Volumn 34, Issue 5, 1988, Pages 461-464

  Lindholm, A ^a   Henricsson, S ^a   Lind, M ^a   Dahlqvist, R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cyclosporin A; immunosuppression; intra interindividual variation; organ transplantation; plasma concentrations; systemic availability

Indexed keywords

CYCLOSPORIN;

DRUG BIOAVAILABILITY; DRUG PROTEIN BINDING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NORMAL VALUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINS; HUMANS; LIPOPROTEINS; MALE;

EID: 0023932808     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF01046702     Document Type: Article

References (29)

1. Cyclosporin A in patients receiving renal allografts from cadaver donors
2. A randomized clinical trial of cyclosporine in cadaveric renal transplantation
3. Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors: Preliminary results of a European multicentre trial
4. Cyclosporine: A new immunosuppressive agent for organ transplantation
5. Cyclosporin A: Pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipients of allogeneic bone-marrow grafts
6. Pharmacokinetic study of cyclosporin A in patients with primary biliary cirrhosis
7. Cyclosporine kinetics in renal transplantation
8. The effect of food on cyclosporine absorption
9. Clinical pharmacokinetics of cyclosporin A in bone marrow transplant patients
10. Cyclosporine absorption following orthotopic liver transplantation
11. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay
12. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplantation
13. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects
14. A new method for measuring the free fraction of cyclosporin in plasma by equilibrium dialysis
15. In vitro stability of cyclosporin?
16. Semi-automated high-performance liquid chromatographic determination of cyclosporine A in whole blood using one-step sample purification and column-switching
17. Role of bile salts on cyclosporine absorption in dogs
18. Correspondence
19. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation
20. Excretion of cyclosporine and its metabolites in human bile
21. The impact of time-dependent phenomena on bioequivalence studies
22. Comparative bioavailability of trazodone formulations using stable isotope methodology
23. Implications of intraindividual variability in bioavailability studies of furosemide
24. Intrasubject variability in methyldopa bioavailability
25. Pharmacokinetics of oxazepam in healthy volunteers
26. Intraindividual variation in drug disposition
27. Lack of influence of an intensive antacid regimen on theophylline bioavailability
28. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood
29. Is plasma lipoprotein pattern of importance for treatment with cyclosporine?